Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05762536
Title Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC (DAROTAXEL)
Acronym DAROTAXEL
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Erasmus Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD


No variant requirements are available.